中华顶尖财经--信息搜索

信息搜索

信息关键字：医

『查询2022年信息』『查询2021年信息』『查询2020年信息』『查询2019年信息』『查询2018年信息』『查询2017年信息』『查询2016年信息』
『查询2015年信息』『查询2014年信息』『查询2013年信息』『查询2012年信息』『查询2011年信息』『查询2010年信息』『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]

·9月11日通化金马涨停分析：阿尔茨海默病，医药，中药概念热股2023-9-11 17:24:08

·9月11日灵康药业涨停分析：西藏，阿尔茨海默病，医药概念热股2023-9-11 17:15:43

·胡锡进：医疗反腐调整得当，对国家政策保持信心2023-9-11 16:55:41

·9月11日科森科技涨停分析：医疗器械，电子烟，机器人概念热股2023-9-11 16:33:49

·收评：沪指放量涨0.84%，酿酒、金融等板块拉升，医药股活跃2023-9-11 16:29:46

·医药的超跌反弹持续性有待观察2023-9-11 16:16:08

·机构论市：指数放量反攻医药AI携手走高！2023-9-11 16:16:04

·医药生物行业周报：2022年度药品审评报告发布，关注中药、儿童药发展机会2023-9-11 13:48:25

·医药生物行业跟踪周报：老龄化促使带疱疫苗空间广阔，推荐智飞生物2023-9-11 12:46:00

·恒瑞医药羟乙磺酸达尔西利片、醋酸阿比特龙片（I）获得药物临床试验批准2023-9-11 12:45:32

·医药行业周报：医药中报落地，业绩分化2023-9-11 12:24:46

·锦波生物：医疗器械产品营收同比增加140.25%拟派发现金红利3404万元2023-9-11 12:12:07

·拥抱全渠道时代，2023伯云会邀你共探全球化视野下的中国医药产业发展2023-9-11 10:32:09

·乐普医疗：生物可降解卵圆孔未闭封堵器获得NMPA注册批准2023-9-10 18:23:35

·恒瑞医药：获得药物临床试验批准通知书2023-9-10 15:43:44

·1股获买入评级最新:复星医药 2023-9-10 8:26:02

·深圳医保政策修订 10月1日起实施2023-9-9 10:22:34

·股票行情快报：中红医疗（300981）9月8日主力资金净卖出7.58万元2023-9-9 3:46:56

·日照岚山卫健局、兴岚控股集团考察盛泉养老：洽谈合作医康养项目2023-9-9 1:19:24

·生物医药迎“回购潮”：“生长激素第一股”长春高新拟以约2亿资金回购公司股份2023-9-8 20:20:03

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]